Morphological and molecular uniqueness of acral melanoma

Expert Review of Dermatology

Volumn 2, Issue 2, 2007, Pages 125-131

  Saida, Toshiaki ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

acral melanoma; cancer stem cell; clinical significance; dermoscopy; genetic alterations

Indexed keywords

EID: 84987662556     PISSN: 17469872     EISSN: 17469880     Source Type: Journal    
DOI: 10.1586/17469872.2.2.125     Document Type: Article

References (29)

1. Clark WH Jr, Goldman LI, Mastrangelo MJ. Human Malignant Melanoma. Grune & Stratton, NY, USA (1979).
2. Saida T, Koga H, Yamazaki Y, Tanaka M. Acral melanoma. In: Color Atlas of Melanocytic Lesions of the Skin. Soyer HP Argenziano, G, Hofmann-Wellenhof R, Johr RH (Eds). Springer, Heidelberg, Germany (2007) (In press).
3. Stevens NG, Liff JM, Weiss NS. Plantar melanoma: is the incidence of melanoma of the sole of foot really higher in blacks than whites? Int. J. Cancer 45, 691–693 (1990).
4. Balch CM, Buzaid AC, Soong S-J et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J. Clin. Oncol. 19, 3635–3648 (2001).
5. Saida T, Oguchi S, Miyazaki A. Dermoscopy for acral pigmented skin lesions. Clin. Dermatol. 20, 279–285 (2002).
6. Saida T, Miyazaki A, Grin CM. Acrolentiginous melanoma. In: Atlas of Dermoscopy. Marghoob AA, Braun R, Kopf AW (Eds). Taylor & Francis, London, UK 221–223 (2005).
7. Ishihara K, Saida T, Yamazaki A. Updated statistical data for malignant melanoma in Japan. Int. J. Clin. Oncol. 6, 109–116 (2001).
8. Phan A, Touzet S, Dalle S et al. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases. Br. J. Dermatol. 155, 561–569 (2006).
9. Szabo G. The number of melanocytes in human epidermis. Br. Med. J. 1, 1016–1017 (1954).
10. Argenziano G, Soyer HP, Chimenti S et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J. Am. Acad. Dermatol. 48, 679–693 (2003).
11. Saida T, Oguchi S, Ishihara Y. In vivo observation of magnified features of pigmented lesions on volar skin using video macroscope. Arch. Dermatol. 131, 298–304 (1995).
12. Oguchi S, Saida T, Koganehira Y et al. Characteristic epiluminescent microscopic features of early malignant melanoma on glabrous skin. Arch. Dermatol. 134, 563–568 (1998).
13. Miyazaki A, Saida T, Koga H et al. Anatomical and histopathological correlates of the dermoscopic patterns seen in melanocytic nevi on the sole. J. Am. Acad. Dermatol. 53, 230–236 (2005).
14. Malvehy J, Puig S. Dermoscopic patterns of benign volar melanocytic lesions in patients with atypical mole syndrome. Arch. Dermatol. 140, 538–544 (2004).
15. Altamura D, Altobelli E, Micantonio T, Piccolo D, Furgnoli MC, Peris K. Dermoscopic patterns of acral melanocytic nevi and melanomas in a white population in central Italy. Arch. Dermatol. 142, 1123–1128 (2006).
16. Saida T, Miyazaki A, Oguchi S et al. Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: a retrospective multicenter study in Japan. Arch. Dermatol. 140, 1233–1238 (2004).
17. Bastian BC, Kashani-Sabet M, Hamm H et al. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res. 60, 1968–1973 (2000).
18. Curtin JA, Fridlyand J, Kageshita T et al. Distinct sets of genetic alterations in melanoma. N. Engl. J. Med. 353, 2135–2147 (2005).
19. Yamaura M, Takata M, Miyazaki A, Saida T. Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ. Arch. Dermatol. 141, 1413–1418 (2005).
20. Ishihara Y, Saida T, Miyazaki A et al. Early acral melanoma in situ: correlation between the parallel ridge pattern on dermoscopy and microscopic features. Am. J. Dermatopathol. 28, 21–27 (2006).
21. Saida T. The concept of de novo origin of cutaneous malignant melanoma. Eur. J. Dermatol. 4, 252–254 (1994).
22. Saida T. Lessons learned from studies of the development of early melanoma. Int. J. Clin. Oncol. 10, 371–374 (2005).
23. Grichnik JM, Burch JA, Schulteis RD et al. Melanoma, a tumor based on a mutant stem cell? J. Invest. Dermatol. 126, 142–153 (2006).
24. Nishimura EK, Jordan SA, Oshima H et al. Dominant role of the niche in melanocyte stem-cell fate determination. Nature 416, 854–860 (2002).
25. Moriyama M, Osawa M, Mal S-S et al. Notch signaling via Hes1 transcription factor maintains survival of melanoblasts and melanocytes stem cells. J. Cell Biol. 173, 333–339 (2006).
26. Bastian BC. Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer. Oncogene 22, 3081–3086 (2003).
27. Maldonado JL, Fridlyand J, Patel H et al. Determinants of BRAF mutations in primary melanomas. J. Natl Cancer Inst. 95, 1878–1890 (2003).
28. Ackerman AB. Malignant melanoma: a unifying concept. Hum. Pathol. 11, 591–595 (1980).
29. Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J. Clin. Oncol. 24, 4340–4346 (2006).